Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13195-023-01260-3
PubMed Identifier: 37312157
Publication URI: http://europepmc.org/abstract/MED/37312157
Type: Journal Article/Review
Volume: 15
Parent Publication: Alzheimer's research & therapy
Issue: 1